BLSM
BlossomHill Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$22.01
+9.94%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -4.43x
- Price / sales
- —
- Price / cash flow
- -14.37x
Enterprise value
- Enterprise value
- $581.5M
- EV / sales
- —
- EV / EBITDA
- -9.15x
- EV / EBIT
- -9.08x
- Market cap
- $674.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026